Lung cancer screening

SJ Adams, E Stone, DR Baldwin, R Vliegenthart, P Lee… - The Lancet, 2023 - thelancet.com
Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Screening for lung cancer: US Preventive Services Task Force recommendation statement

AH Krist, KW Davidson, CM Mangione, MJ Barry… - Jama, 2021 - jamanetwork.com
Importance Lung cancer is the second most common cancer and the leading cause of
cancer death in the US. In 2020, an estimated 228 820 persons were diagnosed with lung …

Contemporary issues in the implementation of lung cancer screening

S Lam, M Tammemagi - European Respiratory Review, 2021 - Eur Respiratory Soc
Lung cancer screening with low-dose computed tomography can reduce death from lung
cancer by 20–24% in high-risk smokers. National lung cancer screening programmes have …

Sybil: a validated deep learning model to predict future lung cancer risk from a single low-dose chest computed tomography

PG Mikhael, J Wohlwend, A Yala, L Karstens… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Low-dose computed tomography (LDCT) for lung cancer screening is effective,
although most eligible people are not being screened. Tools that provide personalized …

USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study

MC Tammemägi, M Ruparel, A Tremblay… - The Lancet …, 2022 - thelancet.com
Background Lung cancer is a major health problem. CT lung screening can reduce lung
cancer mortality through early diagnosis by at least 20%. Screening high-risk individuals is …

Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?

R Feng, Q Su, X Huang, T Basnet, X Xu… - Cancer …, 2023 - Wiley Online Library
Background Over the past four decades, the Chinese government has conducted three
surveys on the distribution of causes of death and built cancer registration. In order to shine …

Deep learning for malignancy risk estimation of pulmonary nodules detected at low-dose screening CT

KV Venkadesh, AAA Setio, A Schreuder, ET Scholten… - Radiology, 2021 - pubs.rsna.org
Background Accurate estimation of the malignancy risk of pulmonary nodules at chest CT is
crucial for optimizing management in lung cancer screening. Purpose To develop and …

Blood-based biomarker panel for personalized lung cancer risk assessment

JF Fahrmann, T Marsh, E Irajizad, N Patel… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To investigate whether a panel of circulating protein biomarkers would improve
risk assessment for lung cancer screening in combination with a risk model on the basis of …

Risk model–based lung cancer screening: a cost-effectiveness analysis

I Toumazis, P Cao, K de Nijs, M Bastani… - Annals of internal …, 2023 - acpjournals.org
Background: In their 2021 lung cancer screening recommendation update, the US
Preventive Services Task Force (USPSTF) evaluated strategies that select people based on …

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges

K Ten Haaf, CM van der Aalst… - … journal of cancer, 2021 - Wiley Online Library
Randomised clinical trials have shown the efficacy of computed tomography lung cancer
screening, initiating discussions on whether and how to implement population‐based …